AlphaFold predicted structure
FBP1 · P09467

Mean pLDDT
94.3/ 100
Very high
338 residues
Confidence breakdown
- Very high(≥ 90)88%
- Confident(70–90)10%
- Low(50–70)2%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
fructose-bisphosphatase 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalGlycogen storage disease
BIALLELIC, autosomal or pseudoautosomalKetotic hypoglycaemia
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalfructose-1,6-bisphosphatase deficiency
disorder of glycogen metabolism
Glycogen storage disease due to glycogenin deficiency
hereditary disease
anxiety disorder
Alzheimer disease
Abnormal nasolacrimal system morphology
multinodular goiter
ovarian neoplasm
diabetes mellitus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Fructose-1,6-bisphosphatase 1
Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations, acting as a rate-limiting enzyme in gluconeogenesis. Plays a role in regulating glucose sensing and insulin secretion of pancreatic beta-cells. Appears to modulate glycerol gluconeogenesis in liver. Important regulator of appetite and adiposity; increased expression of the protein in liver after nutrient excess increases circulating satiety hormones and reduces appetite-stimulating neuropeptides and thus seems to provide a feedback mechanism to limit weight gain
FBP1 · P09467

Mean pLDDT
94.3/ 100
Very high
338 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0